Comparison
Why is MaxCyte, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate -129.66% of over the last 5 years
2
Flat results in Sep 25
- OPERATING CASH FLOW(Y) Lowest at USD -39.54 MM
- ROCE(HY) Lowest at -23.19%
- DEBT-EQUITY RATIO (HY) Highest at -48.57 %
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -76.51%, its profits have fallen by -17%
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -76.51% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is MaxCyte, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
MaxCyte, Inc.
-78.11%
-1.20
71.16%
S&P 500
13.68%
0.71
19.28%
Quality key factors
Factor
Value
Sales Growth (5y)
-6.41%
EBIT Growth (5y)
-129.66%
EBIT to Interest (avg)
-37.18
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.69
Sales to Capital Employed (avg)
0.19
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
81.66%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.48
EV to EBIT
0.36
EV to EBITDA
0.40
EV to Capital Employed
-0.24
EV to Sales
-0.52
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-23.20%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Movement
7What is working for the Company
NET PROFIT(HY)
Higher at USD -21.88 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 1.23 times
OPERATING PROFIT(Q)
Highest at USD -9.96 MM
-10What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -39.54 MM
ROCE(HY)
Lowest at -23.19%
DEBT-EQUITY RATIO
(HY)
Highest at -48.57 %
NET SALES(Q)
Lowest at USD 6.83 MM
EPS(Q)
Lowest at USD -0.12
Here's what is working for MaxCyte, Inc.
Net Profit
Higher at USD -21.88 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Inventory Turnover Ratio
Highest at 1.23 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Operating Profit
Highest at USD -9.96 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Depreciation
Highest at USD 1.28 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for MaxCyte, Inc.
Operating Cash Flow
Lowest at USD -39.54 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Net Sales
Lowest at USD 6.83 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Net Sales
Fallen at -16.35%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
EPS
Lowest at USD -0.12
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
Debt-Equity Ratio
Highest at -48.57 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio






